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Introduction
Staphylococcal biofilms are the leading cause of device-
related infections of medical relevance. Staphylococcus aur-
eus is an important cause of metal biomaterial, bone joint
and soft tissue infections, while Staphylococcus epidermidis
is seen more often in polymer-associated infections (Go¨tz
2004). Together, the Gram-positive pathogens Staph. aureus,
Staph. epidermidis and Enterococcus faecalis represent
more than 50% of the species isolated from patients with
medical device-associated infections (Donelli et al. 2007).
Many infections such as otitis media, sinusitis, choles-
teatoma, tonsillitis and adenoiditis are caused by biofilm-
forming mucosal pathogens (Pseudomonas aeruginosa,
Staph. aureus, Streptococcus pneumoniae, Haemophilus
influenzae and Moraxella catarrhalis). The role of biofilms
in the persistence of chronic infection of otolaryngology
interest was first recognized in otitis media. Further stud-
ies have confirmed the presence of biofilms in chronic
tonsillitis and in chronic rhinosinusitis (Post et al. 2007).
The treatment of these kinds of infections is compli-
cated as microbial biofilms are typically highly resistant to
conventional antibiotics (Gilbert et al. 1997). The discov-
ery of anti-infective agents active not only against plank-
tonic micro-organisms but also against biofilms
represents an important goal (Projan and Youngman
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Abstract
Aims: Staphylococcal biofilm-associated infections are resistant to conventional
antibiotics. Consequently, new agents are needed to treat them. With this aim,
we focused on the effector cells (coelomocytes) of the sea urchin Paracentrotus
lividus immune system.
Methods and Results: We tested the activity of the 5-kDa peptide fraction of
the cytosol from coelomocytes (5-CC) against a group of Gram-positive,
Gram-negative bacteria and fungi. We determined minimal inhibitory concen-
trations (MICs) ranging from 253Æ7 to 15Æ8 mg ml)1. We observed an inhibi-
tory activity and antibiofilm properties of 5-CC against staphylococcal biofilms
of reference strains Staphylococcus epidermidis DSM 3269 and Staphylococcus
aureus ATCC 29213. The antimicrobial efficacy of 5-CC against the biofilms of
clinical strain Staph. epidermidis 1457 was also tested using live ⁄dead staining
in combination with confocal laser scanning microscopy. At a sub-MIC
concentration (31Æ7 mg ml)1) of 5-CC the formation of young (6-h old) and
mature (24-h old) staphylococcal biofilms was inhibited.
Conclusions: The biological activity of 5-CC could be attributed to three pep-
tides belonging to the sequence segment 9–41 of a beta-thymosin of P. lividus.
Significance and Impact of the Study: The effector cells of P. lividus represent
an interesting source of marine invertebrates-derived antimicrobial agents in
the development of new strategies to treat staphylococcal biofilms.
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2002). The immune system of marine invertebrates is a
poorly explored source of new antimicrobial agents. In
particular, we focused on the coelomocytes effector cells
of the sea urchin Paracentrotus lividus immune system.
The coelomocytes of P. lividus show a wide repertoire of
immunological functions, including cellular recognition,
phagocytosis and cytotoxicity (Arizza et al. 2007). A
60-kDa protein, which showed antibacterial activity, has
been isolated from lysates of coelomocytes from P. lividus
(Stabili et al. 1996). Furthermore, from biological and
ecological points of view, there are two good reasons to
justify the choice of this species: (i) it is a long-living
organism and (ii) it lives in an infralitoral environment
where it is exposed to pathogenic attacks from invading
micro-organisms. The survival and fitness of P. lividus in
marine environments suggest that its innate immune
system is potent and effective.
In this study, we focused on antimicrobial peptides
(AMPs) characterized by a small molecular size
(<10 kDa) and a wide antibacterial activity (Boman 1995;
Cellura et al. 2007). A large variety of AMPs have been
described in marine invertebrates: defensin (Hubert et al.
1996), myticin (Mitta et al. 1999) and mytilin (Mitta
et al. 2000) in mussels; penaeidin (Destoumieux et al.
2000) in shrimp; tachyplesin and polyphemusin in horse-
shoe crab (Miyata et al. 1989), clavanin and styelin in
ascidians (Lee et al. 1997), and Ci-PAP-A22 in Ciona
intestinalis (Fedders and Leippe 2008). As far as we know,
there are no studies about AMPs in P. lividus. Thus, we
turned our attention to the evaluation of the antimicro-
bial activity of a 5-kDa peptide fraction from coelomo-
cytes cytosol (5-CC) of the above-mentioned species
against a group of important human pathogens. We also
showed the in vitro efficacy of 5-CC in inhibiting the for-
mation of Staph. epidermidis 1457 biofilm, a clinical strain
isolated from an infected central venous catheter, as well
as the antibiofilm activity of 5-CC against reference
staphylococcal biofilms.
Materials and methods
Microbial strains
The strains used were Staph. aureus ATCC 25923, Staph.
aureus ATCC 29213, Staph. aureus ATCC 43866, Staph.
epidermidis DSM 3269, Staph. epidermidis 1457, Escherichia
coli ATCC 25922, Ps. aeruginosa ATCC 9027, Candida albi-
cans ATCC 10231 and Candida tropicalis ATCC 13803.
Animals and bleeding procedure
Sea urchins collected from the Gulf of Palermo, were
maintained at 15C in marine aquaria equipped with
biological and physical filters and fed with commercial
invertebrate food (Azoo; Taikong Corp., Taipei, Taiwan).
The coelomic fluid (CF) was withdrawn by inserting the
needle of a syringe, preloaded with isosmotic anticoagu-
lant solution (20 mmol l)1 Tris, 0Æ5 mol l)1 NaCl,
70 mmol l)1 EDTA pH 7Æ5) (ISO–EDTA) into the peris-
tomal membrane. After centrifugation (900 g for 10 min
at 4C), the coelomocytes were washed two times in
ISO–EDTA and resuspended at 5 · 106 cells ml)1 in
ISO–EDTA. Coelomocyte number was calculated with a
haemocytometer chamber, and dead cells were evaluated
by using the eosin-Y exclusion test (0Æ5% in ISO–
EDTA).
Preparation of coelomocyte lysate supernatant
Acid-soluble protein extracts were prepared according to
the previously described method (Mercado et al. 2005)
with some slight modifications. Coelomocytes (10 · 106)
were suspended in a solution of 10% acetic acid in ISO
without EDTA, sonicated (SonifierBranson, model B-15;
Danbury, CT, USA) for 1 min at 0C (1 pulse s)1, 70%
duty cycle) and centrifuged at 27 000 g for 30 min at 4C
to remove any precipitate. After centrifugation, the super-
natants were filtered (0Æ45 lm, Millex; Millipore Corp.)
and freeze-dried to be later redissolved in H2O.
A 5-kDa peptide fraction of the cytosol from celomo-
cytes (5-CC) was obtained by using a filter through a
membrane with a nominal size of 5 kDa (Ultrafree-0.5
PBCC Centrifugal filter Unit; Amicon Millipore, MA,
USA).
Minimum inhibitory concentrations (MIC)
MICs were determined by a micromethod as previously
described (Schillaci et al. 2005).
Biofilms susceptibility testing: static chamber system
Biofilms of the clinical strain Staph. epidermidis 1457
were cultivated in coverglass cell culture chambers
(Nunc, Roskilde, Denmark) (Jager et al. 2005). Over-
night cultures of Staph. epidermidis in Tryptic Soy Broth
(TSB, Oxoid) medium supplemented with 0Æ25%
glucose were diluted to OD600 = 0Æ001 then inoculated
into wells of chambers (1Æ5 ml per well) and incubated
at 37C for 6 h (young biofilm) and 24 h (mature
biofilm). To evaluate the inhibitory activity of biofilm
formation, a sub-MIC concentration of 5-CC equal to
31Æ7 mg ml)1 was directly added to the bacterial suspen-
sion at time zero.
After incubation, the chambers were washed gently four
times with sterile phosphate-buffered saline (PBS), then
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stained with 1 lmol l)1 SYTO9 (green fluorescent stain
for living cells) and 1 lmol l)1 Propidium Iodide (PI, red
fluorescent stain for dead cells; Molecular Probes Inc.,
Eugene, OR, USA) for 15 min and observed with a
confocal laser scanning microscope (CLSM).
Microscopy and image acquisition
The microscopic observations and image acquisition were
performed with a Zeiss LSM 510 CLMS (Carl Zeiss, Jena,
Germany) equipped with detectors and filter sets for
monitoring staining with LIVE ⁄DEAD kit. Biofilm images
were obtained using a 63· ⁄ 1Æ4 objective or a 40· ⁄ 1Æ3i
objective. Simulated section images were generated using
the imaris software package (Bitplane AG, Zurich,
Switzerland).
Staphylococcal biofilm susceptibility testing: crystal
violet method
Staphylococcus epidermidis DSM 3269 and Staph. aureus
ATCC 29213 were grown on TSB (Sigma) containing 2%
glucose, for 24 h at 37C in a shaking bath and then
diluted 1 : 200 as to obtain a suspension whose optical
density (OD) at 570 nm was about 0Æ015. The diluted
suspension was added to the wells (100 ll per well) of a
polystyrene microtiter plate and incubated for 24 h at
37C; then the wells were washed three times with 200 ll
of sterile PBS and finally air-dried in inverted position at
37C. Each of the wells was then filled with 100 ll of
Mueller–Hinton broth. With the exception of the positive
(growth) control wells, the Mueller–Hinton broth was
supplemented with 5-CC at concentrations, obtained by
dilution, ranging from 126Æ8 to 7Æ9 mg ml)1 and incu-
bated at 37C for 24 h. Following this incubation period,
the medium was removed, the plates were air-dried in
inverted position, and then each well was stained with a
crystal violet solution as described (Pitts et al. 2003). The
optical density (OD) of each well was read by a micro-
plate reader (ELX 800; Bio-Tek instruments) at 570 nm.
Comparing the average of optical density of the growth
control (not treated) wells with that of sample wells, we
calculated the inhibition percentages for each concentra-
tion of the 5-CC by the following formula:
OD growth control ) OD sample ⁄OD growth control · 100
The ability to prevent formation of staphylococcal
biofilms was assessed by directly adding 5-CC at con-
centrations ranging from 126Æ8 to 7Æ9 mg ml)1 in
100 ll of the bacterial suspensions inoculated in the
wells of a 96-well plate at 37C at time zero. After
24 h, the wells were washed, stained and read as
already described.
Identification of 5-kDa peptide fraction
(5-CC) components
SDS-polyacrylamide gel electrophoresis
SDS-PAGE in slab gel was performed according to a
described method (Laemmli 1970); proteins were
stained with Coomassie Blue. Gels were calibrated with
molecular weight standard proteins (Sigma), and the
molecular weights of the resulting bands were calculated
by image analysis software (AlphaEasyFC; Alpha
Innotech Corp.). Gels were satined with silver stain
(Bio-Rad). The average of three independent experi-
ments was evaluated.
RP-HPLC-nESI-MSMS
HPLC-grade water and CH3CN were provided by Carlo
Erba (Milan, Italy). Capillary RP-HPLC ⁄nESI-MSMS was
performed using an Ultimate 3000 LC system (Dionex
Corporation, Sunnyvale, CA, USA) coupled online with a
linear ion trap nano-electrospray mass spectrometer
(LTQ; Thermo Fischer Scientific, San Jose, CA, USA).
Ionization was performed with liquid junction and a non-
coated capillary probe (20 mm i.d.; New Objective).
An amount of 2 mg of 5-CC was freeze-dried and
redissolved in H2O–0Æ1% formic acid (FA) (1 mg ml
)1).
Ten microlitres of this solution was directly loaded onto
a C18 l-precolumn cartridge (0Æ3 lm · 5 mm, 100 A˚,
5 lm, PepMap; Dionex) equilibrated with 0Æ1% aqueous
FA at a flow rate of 20 ll min)1 for 4 min. Subsequently,
the extract was applied onto a C18 capillary column
(150 · 0Æ18 mm, 300 A˚, 5 lm; Thermo Electron) and
eluted at room temperature with a linear gradient of
CH3CN-0Æ1% FA ⁄H2O–0Æ1% FA from 5% to 50% in
50 min at a flow rate of 2 ll min)1.
Repetitive mass spectra were acquired from m ⁄ z 350 to
2000 mass range in positive ion mode using the following
electrospray ion source parameters: capillary temperature,
220C; spray voltage, 1Æ8 kV.
Peptide ions were analysed by the Nth-dependent
method as follows: (i) full MS scan (mass to charge ratio
350 : 2000); (ii) ZoomScan (scan two major ions with
higher resolution; isolation width 2 Da); and (iii) MS ⁄MS
of these two ions (Q 0Æ250, activation time 5 50 of the
ms, collision energy 23 a.u.).
Database search and protein identification
MSMS data were used to perform protein identifications
by searching in nonredundant protein sequence database
(NCBInr) using the MOWSE algorithm as implemented
in the MS search engine MASCOT (Matrix Science)
(http://www.matrixscience.com). The MSMS data were
extracted as DTA files by means of Bioworks 3.2 (Thermo
Fischer Scientific) and converted into Mascot generic
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format. The following parameters were used for database
searches: taxonomy: Eukaryota; no enzyme as cleavage
specificity; mass tolerance of (1Æ2 Da for the precursor
ions and a tolerance of 0Æ6 Da for the fragment ions;
allowed modifications: oxidation of Met (variable), trans-
formation of N-terminal Gln and N-terminal Glu residue
in the pyroglutamic acid form (variable).
Only proteins that met the following criteria were
accepted as unambiguously identified: MASCOT score
> 76 [probability-based MOWSE score: )10 · log(P),
where P is the probability that the observed match is a
random event. Score >76 indicates identity or extensive
homology (P < 0Æ05)]. Additionally, every peptide used
for protein identification was checked for (i) y-ion
series: ‡80% of the y-ions should be available; (ii) pres-
ence of the b-ions; and (iii) e value <1 · 10)10 (proba-
bility that the observed match is a random peptide).
Results
Antimicrobial activity of 5-CC
The antimicrobial activity of the 5-kDa peptide fraction
from coelomocytes cytosol (5-CC) of P. lividus expressed
as MICs against microbial reference strains (planktonic
cells) is listed in Table 1. We tested 5-CC at concentra-
tions ranging from 507Æ5 to 7Æ9 mg ml)1 against a group
of Gram-positive and Gram-negative bacterial reference
strains and against two human pathogen fungi. The 5-CC
resulted active against all tested microbial strains with
MIC values ranging from 15Æ8 mg ml)1 against C. tropi-
calis ATCC 13803 to 253Æ7 mg ml)1 against Ps. aeruginosa
ATCC 9027.
5-CC resulted effective, with MIC values ranging from
253Æ7 to 63Æ4 mg ml)1, against planktonic staphylococcal
strains Staph. epidermidis DSM 3269, Staph. epidermidis
1457, Staph. aureus ATCC 29213, Staph. aureus ATCC
25923 and methicillin-resistant Staph. aureus ATCC
43866.
Antibacterial activity of 5-CC against
staphylococcal biofilms
The biofilm of clinical strain Staph. epidermidis 1457 was
tested for its susceptibility to 5-CC by CLSM combined
with viability staining. A treatment with a sub-MIC con-
centration of 5-CC equal to 31Æ7 mg ml)1 (the MIC value
against planktonic form of the same strain was 126Æ8
mg ml)1) was found to inhibit adhesion, and biofilm
formation after 6 h (young biofilm) and 24 h (mature
biofilm) with a significant reduction of viable cells was
evident (Fig. 1).
The activity of 5-CC on biofilm formation and against
preformed 24-h old biofilms of reference strains
Staph. epidermidis DSM 3269 and Staph. aureus ATCC
29213 was investigated by crystal violet method. At con-
centrations of 5-CC between 126Æ8 and 7Æ9 mg ml)1,
interesting inhibition percentages ranging from 85%
to 50% were found for preventative activity of Staph.
epidermidis biofilm formation. For Staph. aureus, we
obtained lower inhibition percentages ranging from 61%
to 28Æ4% at concentrations of 5-CC between 126Æ8 and
15Æ8 mg ml)1 (Fig. 2).
The antibiofilm activity of 5-CC against preformed
24-h old Staph. aureus ATCC 29213 biofilms at
concentrations ranging from 126Æ8 and 15Æ8 mg ml)1 was
estimated, and inhibition percentages from 61Æ8 to 37Æ4
were obtained. With similar concentrations of 5-CC,
weaker antibiofilm effects were found against preformed
Staph. epidermidis DSM 3269 biofilms (Fig. 3).
Identification of 5-kDa peptide fraction
(5-CC) components
Three principal peptides were detected by SDS-PAGE of
the 5-CC fraction. The size of the peptides was estimated
by comparing them to molecular weight standard pro-
teins (Fig. 4). In order to confirm the presence of pep-
tides and determine their sequence, the 5-CC fraction was
subjected to RP-HPLC ⁄nESI-MSMS. The MSMS data
obtained were used to perform database searches and
Table 1 Antimicrobial activity of 5-kDa peptide fraction from
celomocytes (5-CC). Values in vitro expressed in mg ml)1 for all strains
tested
5-CC (5 kDa total cytosol)
Minimum inhibitory concentrations
(MIC) values in mg ml)1
Staphylococcus aureus
ATCC 29213
126Æ8
Staph. aureus
ATCC 25923
63Æ4
Staph. aureus
ATCC 43866
63Æ4
Staphylococcus epidermidis
1457
126Æ8
Staph. epidermidis
DSM 3269
253Æ7
Escherichia coli
ATCC 25922
126Æ8
Pseudomonas aeruginosa
ATCC 9027
253Æ7
Candida albicans
ATCC 10231
31Æ7
Candida tropicalis
ATCC 13813
15Æ8
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allowed the identification of three peptides belonging to
the sequence segment 9–41 of a beta-thymosin of P. livi-
dus (NCBInr acc. no gi|22474470) whose molecular mass
is 4592 Da. The sequences of identified peptides are
reported in Table 2.
Discussion
The antimicrobial defence system of marine invertebrates
is based solely on an innate immune system that includes
both humoral and cellular responses. AMPs constitute
30 µm
40 µm30 µm 
(a) (b) 
(c) (d) 
Figure 1 Preventative inhibitory activity of
5-CC. (a) Staphylococcus epidermidis 1457
growth control 6-h old; (b) treated with a
concentration of 31Æ7 mg ml)1 after 6 h; (c)
Staph. epidermidis 1457 growth control 24-h
old; (d) treated with a concentration of
31Æ7 mg ml)1 after 24 h. After 6- or 24-h
treatment, the biofilms were stained with
LIVE ⁄DEAD materials (SYTO9, green; PI, red)
and observed using CLMS. The assays were
repeated at least twice, and similar results
were obtained.
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Figure 2 Preventative inhibitory activity of 5-CC on Staphylococcus
epidermidis DSM 3269 and Staphylococcus aureus 29213 biofilm for-
mation. Activity expressed as inhibition percentages; Values are the
mean of at least three independent determinations. Error bars
represent standard deviations. ( ) Staphylococcus epidermidis and
( ) Staph. aureus.
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Figure 3 Antibiofilm activity of 5-CC against preformed 24-h-old bio-
film of Staphylococcus epidermidis DSM 3269 and Staphylococcus
aureus 29213. Activity expressed as inhibition percentages; Values are
the mean of at least three independent determinations. Error bars
represent standard deviations. ( ) Staphylococcus epidermidis and
( ) Staph. aureus.
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a major component of their humoral immunity. They
comprise short sequences of amino acids ranging around
10–50 amino acids in length and have a net positive
charge because of their excess number of cationic
residues. Marine invertebrates AMPs display broad
antimicrobial spectra, even against human pathogens
(Tincu and Taylor 2004).
In this work, we observed that 5-CC possesses a broad
antimicrobial activity against all tested human pathogens.
Small-sized molecules and broad antimicrobial spectrum
are two common characteristics of AMPs, hence we
employed RP-HPLC ⁄nESI-MSMS to confirm the presence
of AMPs in the 5-CC content. Three principal peptides in
5-CC, whose molecular weights were respectively 1251Æ7,
2088Æ1 and 2292Æ2 Da, were identified: they were the
(9–19), (12–31), (24–41) fragments of a beta-thymosin of
P. lividus.
The beta-thymosins are a family of highly conserved
polar 5-kDa peptides originally thought to be thymic hor-
mones. They are present at high concentrations in almost
every cell from vertebrate phyla, but their presence has
also been reported in marine invertebrates (Safer and
Chowrashi 1997). Thymosin b4, as well as other members
of this ubiquitous peptide family, were identified as the
main intracellular G-actin sequestering peptides (Safer
et al. 1990). Furthermore, several biological effects
are attributed to beta-thymosins: induction of metallo-
proteinases, chemotaxis, angiogenesis and inhibition of
inflammation as well as the inhibition of bone marrow
stem cell proliferation in vertebrates (Huff et al. 2001).
Beta-thymosin is also described as one of the AMP of
platelets from animals and human beings (Tang et al.
2002).
It is possible that the antimicrobial and antistaphylo-
coccal biofilm inhibitory activity of 5-CC is associated
with the three identified peptides that matched with beta-
thymosin of P. lividus. In particular, the smallest peptide,
11 amino acids in length, has a good chance of being an
antimicrobial peptide (Wang and Wang 2004): it has a
net positive charge because of an excess number of lysine
residues, and it has three hydrophobic residues and a
total hydrophobic ratio of 36%. Hydrophobic and
charged residues may permit interaction with bacterial
membranes (Hancock et al. 2006).
Chronic staphylococcal infections and device-related
infections can be attributed to the growth of bacteria as
biofilms. Staphylococcal biofilms are intrinsically resistant
to conventional antibiotics, and currently no effective
therapies that target microbial biofilms exist. Early
removal of the device or surgical interventions remains
the most effective means to treat biofilm-associated infec-
tions (Brady et al. 2008). Therefore, novel antibiofilm
agents, treatments and strategies are needed. The inhibi-
tion of formation of staphylococcal biofilms on surfaces
of medical devices is one of the possible strategies to
combat them.
In our study, we observed an interesting inhibitory
effect of 5-CC at a sub-MIC concentration, either on the
formation of a young biofilm (6-h old) of Staph. epide-
rmidis 1457 or on the formation of a mature biofilm
(24-h old) of the same clinical strain. The susceptibility
to antimicrobial treatment of a biofilm can depend on
the stage of development (age) of the biofilm itself. A
mature biofilm can be more tolerant to antimicrobial
treatment than a young biofilm. Live ⁄dead staining was
used to assay bacterial viability with or without treatment.
As there is no sign of dead cells, the reduction in bacterial
adhesion could be because of an interference of 5-CC
peptides with microbial surface proteins (adhesins, auto-
lysins) that facilitate attachment to plastic surfaces in the
first step of staphylococcal biofilm formation (Patti and
Hook 1994; Heilmann et al. 1997). Of course, further
studies are needed to explain the mechanism of action
of 5-CC in the activity of prevention of adhesion and
biofilm formation.
A B 
1·38 ± 0·1 kDa 
1·99 ± 0·03 kDa 
2·62 ± 0·08 kDa 
kDa 
26·6 
17·0 
14·2 
6·5 
3·5 
1·0 
Figure 4 Silver stain of Tris ⁄ glycine SDS-PAGE of Paracentrotus
lividus cytosol. The samples were running in a 20% gel, stained with.
A: 30 ll of unfractionated cytosol. B: 30 ll of 5-CC. Molecular weight
markers are on the left.
Table 2 Identification of principal peptides of 5-CC by ESI-MS. The
three peptides belonging to the sequence segment 9–41 of a
beta-thymosin of Paracentrotus lividus.
Position ESI-MS calculated MH+ Sequence
9–19 1251Æ7 EVASFDKSKLK
12–31 2293Æ2 SFDKSKLKKAETQEKNTLPT
24–41 2088Æ1 QEKNTLPTKETIEQEKTA
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5-CC also showed a preventative activity and a good
antibiofilm activity against preformed staphylococcal
reference strains.
We believe that 5-CC is an interesting source of anti-
microbial compounds with pharmaceutical potential
(drugs or drug leads) as antistaphylococcal biofilms
agents. Nevertheless, new studies are needed to correlate
the activity of 5-CC with its principal constituents, and
we are currently evaluating and comparing the antimicro-
bial properties of each single peptide and of different
combinations of the three peptides.
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